Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial

Clinical trial NCT00705939 · COMPLETED

Trial details

NCT number: NCT00705939
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gaucher Disease

Start date: 2008-06-01
Primary completion: 2012-05-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.